Literature DB >> 21697000

Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.

Gordana Supic1, Ruzica Kozomara, Nebojsa Jovic, Katarina Zeljic, Zvonko Magic.   

Abstract

Oral squamous cell carcinoma (OSCC) is characterized by high mortality rates. High incidence of local recurrences in the normal-appearing surgical margins of OSCC patients indicates the existence molecular alterations, including DNA methylation, which could not be detectable by histopathologic analysis. The objective of our study was to determine correlation of tumor-related genes hypermethylation detected in histopathologically negative surgical margins with clinical and prognostic parameters. The genes selected for methylation analysis covered a wide range cellular processes including cell cycle control (p16), apoptosis (DAPK and RASSF1A), Wnt signaling (APC, WIF1 and RUNX3), cell-cell adhesion (E-cad), and DNA repair (MGMT and hMLH1). All of 47 patients had histologically confirmed negative surgical margins. For each of patient, samples from primary malignant tissue and the two consecutive surgical margins were taken at the time of surgery. DNA methylation was determined by multiplex nested methylation-specific PCR. Twenty-seven patients were margin-positive for promoter hypermethylation of at least one gene under study. The presence of DAPK promoter hypermethylation detected in surgical margins was associated with the decreased overall survival (p=0.004, log rank test). Multivariate analysis revealed that DAPK promoter hypermethylation in surgical margins is an independent prognostic factor for overall survival, HR=4.105 (1.458-11.555, 95% CI, p=0.007). Hypermethylation of other tumor-related genes under study did not have prognostic significance. These results demonstrate that DNA hypermethylation in histologically negative surgical margins is a frequent event. Promoter hypermethylation of DAPK gene detected in surgical margins may be a useful molecular marker for the poor survival in OSCC patients. Further investigation into the therapeutic potential of these findings in OSCC is warranted.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697000     DOI: 10.1016/j.oraloncology.2011.05.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  25 in total

1.  miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients.

Authors:  Gordana Supic; Katarina Zeljic; Aleksandra Divac Rankov; Ruzica Kozomara; Aleksandra Nikolic; Dragica Radojkovic; Zvonko Magic
Journal:  Clin Oral Investig       Date:  2017-06-14       Impact factor: 3.573

Review 2.  Epigenetic mechanisms in oral carcinogenesis.

Authors:  Jacqueline A Gasche; Ajay Goel
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

Review 3.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

4.  Comparative Evaluation of Immunohistochemical Expression of p16 with p16 Microsatellite Marker by PCR in Surgical Margins of Oral Squamous Cell Carcinoma.

Authors:  Deepa Babji; Ramakant Nayak; Kishore Bhat; Vijayalakshmi Kotrashetti; Jagadish Hosmani; Santosh Dindawar; Smita Pattanshetty
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-10-31

Review 5.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Expression of E-cadherin in oral lichen planus.

Authors:  Yong DU; Haobo Li
Journal:  Exp Ther Med       Date:  2015-07-23       Impact factor: 2.447

Review 7.  DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.

Authors:  Nongnit Laytragoon-Lewin; Lars Erik Rutqvist; Freddi Lewin
Journal:  Med Oncol       Date:  2013-07-04       Impact factor: 3.064

8.  Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.

Authors:  Gordana Supic; Ruzica Kozomara; Katarina Zeljic; Nebojsa Jovic; Zvonko Magic
Journal:  Clin Oral Investig       Date:  2016-03-11       Impact factor: 3.573

9.  Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.

Authors:  Samatha Bhat; Shama Prasada Kabekkodu; Chinchu Jayaprakash; Raghu Radhakrishnan; Satadru Ray; Kapaettu Satyamoorthy
Journal:  Virchows Arch       Date:  2017-03-02       Impact factor: 4.064

10.  Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.

Authors:  Masamichi Hayashi; Gaosong Wu; Jong-Lyel Roh; Xiaofei Chang; Xiufeng Li; Julie Ahn; Marla Goldsmith; Zubair Khan; Justin Bishop; Zhe Zhang; Xian Chong Zhou; Jeremy Richmon; Nishant Agrawal; Wayne M Koch
Journal:  Cancer       Date:  2015-03-13       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.